Arcadia Biosciences, Inc.

RKDA Consumer Defensive Packaged Foods

Arcadia Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, down 3.71% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 35.9% and free cash flow grew 82.1%, each against the same quarter a year earlier.

0.16 0.04 −20.00%
Market cap
$490.0K
P/E
0.0×
Fwd P/E
−1.5×
Dividend yield
—
F-score
3/9
Altman Z
−59.20
Beneish M
−1.84
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

2 3 3 3
ROE
(64.99%) (45.14%) (158.15%) (430.93%)
ROA
(42.54%) (23.32%) (101.82%) (162.72%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(82.90%) (54.33%) (245.08%) (271.95%)
Average Days of Receivables
58.65 31.93 32.60 42.99
Free Cash Flow per Share
(4.45) 0.56 (2.04) (0.85)
Free Cash Flow
(6.09) 0.76 (4.25) (2.54)
Other line items

Show all line items

Columns are period end dates